Efectividad del tratamiento conservador y/o toxina botulínica en la displasia de cadera en parálisis cerebral infantil espástica. Revisión sistemática

Bachelor thesis Spanish; Castilian OPEN
Busto Ruiz, Elena;
  • Subject: Fisioterapia | Parálisis cerebral infantil | Toxina botulínica | Displasia de cadera

Objetivo: Estudiar la efectividad del tratamiento conservador y/o toxina botulínica tipo A en la prevención o tratamiento de la displasia o dislocación de la cadera en PCI espástica. Material y métodos: Se realizó una búsqueda bibliográfica en las bases de d... View more
  • References (13)
    13 references, page 1 of 2

    13.Scrutton D, Baird G. Surveillance measures of the hips in children with bilateral cerebral palsy. Arch Disease Child. 1997; 76:381-384.

    14.Morton RE, Scott B, McClelland V, Henry A. Dislocation of the hip children with bilateral spastic cerebral palsy.1985-2000. Dev Med Child Neurol. 2006; 48:555-558.

    15.Cooke PH, Cole WG, Carey RP. Dislocation of the hip in cerebral palsy: natural history and predictability. J bone Joint Surg Br. 1989; 71-B: 441- 6.

    16.Scrutton D, Baird G, Smeeton N. Hip dysplasia in bilateral cerebral palsy: incidence and natural history in children aged 18 months to 5 years. Dev Med Child Neurol. 2001; 43:586-600.

    17.Department of health. National Service Framework for children, Young People and Maternity Services: Standard 8. London. 2004.

    18. Pountney TE, Mandy A, Green E, Grad PR. Hip subluxation and dislocation in cerebral palsy- a prospective on the effectiveness programmes. Physiother. Res. Int. 2008; 14:000-000.

    19. Pountney T. 2004 Chailey Approach to Postural Management, 2nd Ed. East Sussex: Chailey Heritage Clinical Services; 2004.

    20. Lance JW. The control of muscle tone, reflexes and movement: Robert Wartenberg Lecture. Neurology. 1980 Dec; 30(12):1303-13.

    21. Pidcock FS, Fish DE, Johnson-Greene D, Borras I, McGready J, Silberstein CE. Hip migration percentage in children with cerebral palsy treated with botulinum toxin A. Arch Phys Med Rehabil. 2005; 86:431- 435.

    22. Krach LE, Kriel RL, Gilmartin RC, Swift DM, Storrs BB, Abbott R et ál. Hip status in cerebral palsy after one year of continuous intrathecal baclofen infusion. Ped Neurol. 2004; 30:163168.

  • Metrics
Share - Bookmark